ICY:FRA
Incyte
€ 100,05
arrow_downward
-1,09%(-1,10) 1D
9 okt, 22:00:00 GMT+2 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor ICY genereren…
Openen
€ 100,05
Hoog
€ 100,05
Laag
€ 100,05
Beursw.
22,86 mld.
Gem. vol.
30,00
Volume
0,00
52 wk hoog
€ 115,40
52 wk laag
€ 72,28
Aantal medewerkers
3K
Openen
€ 100,05
Hoog
€ 100,05
Laag
€ 100,05
Beursw.
22,86 mld.
Gem. vol.
30,00
Volume
0,00
52 wk hoog
€ 115,40
52 wk laag
€ 72,28
Aantal medewerkers
3K
Nieuwsartikelen
Van webbronnen en nieuwspartners
The Globe and Mail
·
53 minuten geleden
Incyte (INCY) Receives a Buy from Bank of America Securities
TipRanks
·
20 uur geleden
Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
Barchart.com
·
1 dag geleden
What to Expect From Incyte’s Next Quarterly Earnings Report
BioSpace
·
1 dag geleden
Incyte to Report Third Quarter 2026 Financial Results
Profiel
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Over Incyte
CEO-
Medewerkers2,84K
Opgericht2002
HoofdkantoorWilmington, Delaware, Verenigde Staten
Sector-
Websiteincyte.com